These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2213015)

  • 1. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias.
    Yates CM; Butterworth J; Tennant MC; Gordon A
    J Neurochem; 1990 Nov; 55(5):1624-30. PubMed ID: 2213015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphate-activated glutaminase in relation to Huntington's disease and agonal state.
    Butterworth J; Yates CM; Simpson J
    J Neurochem; 1983 Aug; 41(2):440-7. PubMed ID: 6223989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases.
    Butterworth J; Yates CM; Reynolds GP
    J Neurol Sci; 1985 Feb; 67(2):161-71. PubMed ID: 2858515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
    Yates CM; Simpson J; Gordon A; Maloney AF; Allison Y; Ritchie IM; Urquhart A
    Brain Res; 1983 Nov; 280(1):119-26. PubMed ID: 6228286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmortem human brain pH and lactate in sudden infant death syndrome.
    Butterworth J; Tennant MC
    J Neurochem; 1989 Nov; 53(5):1494-9. PubMed ID: 2795015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in nine enzyme markers for neurons, glia, and endothelial cells in agonal state and Huntington's disease caudate nucleus.
    Butterworth J
    J Neurochem; 1986 Aug; 47(2):583-7. PubMed ID: 2874190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin immunoreactivity in post-mortem brain is increased in Down's syndrome but not in Alzheimer-type dementia.
    Yates CM; Fink G; Bennie JG; Gordon A; Simpson J; Eskay RL
    J Neurol Sci; 1985 Mar; 67(3):327-35. PubMed ID: 3157784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.
    Gluck MR; Thomas RG; Davis KL; Haroutunian V
    Am J Psychiatry; 2002 Jul; 159(7):1165-73. PubMed ID: 12091195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.
    Bowen DM; Smith CB; White P; Davison AN
    Brain; 1976 Sep; 99(3):459-96. PubMed ID: 11871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobar atrophy without Pick bodies.
    Hulette CM; Crain BJ
    Clin Neuropathol; 1992; 11(3):151-6. PubMed ID: 1611728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance.
    Preece P; Cairns NJ
    Brain Res Mol Brain Res; 2003 Oct; 118(1-2):60-71. PubMed ID: 14559355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin-releasing hormone, luteinizing hormone-releasing hormone and substance P immuno-reactivity in post-mortem brain from cases of Alzheimer-type dementia and Down's syndrome.
    Yates CM; Harmar AJ; Rosie R; Sheward J; de Levy GS; Simpson J; Maloney AF; Gordon A; Fink G
    Brain Res; 1983 Jan; 258(1):45-52. PubMed ID: 24010162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased proteins in post-mortem brain in a case of Pick's disease and in Huntington's disease.
    Borthwick NM; Gordon A; Yates CM
    J Neurol Sci; 1985 Dec; 71(2-3):377-86. PubMed ID: 2935597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.
    Arai H; Kosaka K; Iizuka R
    J Neurochem; 1984 Aug; 43(2):388-93. PubMed ID: 6204013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementia.
    Frölich L; Götz ME; Weinmüller M; Youdim MB; Barth N; Dirr A; Gsell W; Jellinger K; Beckmann H; Riederer P
    J Neural Transm (Vienna); 2004 Mar; 111(3):295-310. PubMed ID: 14991456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal nuclear membrane indentation and astrocyte/neuron ratio in Huntington's disease. A quantitative electron microscopic study.
    Roos RA; Bots GT; Hermans J
    J Hirnforsch; 1985; 26(6):689-93. PubMed ID: 2936799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontal lobe degeneration of non-Alzheimer type. Structural characteristics, diagnostic criteria and relation to other frontotemporal dementias.
    Brun A; Passant U
    Acta Neurol Scand Suppl; 1996; 168():28-30. PubMed ID: 8997416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parvalbumin-immunoreactive neurons in the cortex in Pick's disease.
    Arai H; Noguchi I; Makino Y; Kosaka K; Heizmann CW; Iizuka R
    J Neurol; 1991 Jul; 238(4):200-2. PubMed ID: 1895150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease.
    Mastrogiacomo F; Bergeron C; Kish SJ
    J Neurochem; 1993 Dec; 61(6):2007-14. PubMed ID: 8245957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on neurotransmitter markers of the basal ganglia in Pick's disease, with special reference to dopamine reduction.
    Kanazawa I; Kwak S; Sasaki H; Muramoto O; Mizutani T; Hori A; Nukina N
    J Neurol Sci; 1988 Jan; 83(1):63-74. PubMed ID: 2450180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.